Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-02-20
2007-02-20
Salimi, Ali R. (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S006120, C435S007100
Reexamination Certificate
active
10885862
ABSTRACT:
This invention provides methods of screening for compounds that inhibit herpesviral transcription and replication. The methods comprise screening test compounds for ability to enhance the activity of homeodomain transcription factor PDX1 in repressing transcription of herpesviral genes (e.g., the IE gene of cytomegalovirus). Transcriptional repression by PDX1 can be monitored using an expression vector comprising a reporter gene operably linked to a PDX1-binding, upstream transcription regulatory sequence of the herpesvirus. The invention further provides methods and pharmaceutical compositions for stimulating PDX1-mediated transcriptional repression in a subject and for treating diseases and conditions associated with herpesviral infection.
REFERENCES:
Swift et al, Molecular and Cellular Biology, 1998, vol. 18, No. 9, pp. 5109-5120.
PCT International Search Report mailed on Jan. 7, 2005 for International Application No. PCT/US2004/22341.
Meier et al. Requirement of Multiple cis-Acting Elements in the Human Cytomegalovirus Major Immediate-Early Distal Enhancer for Viral Gene Expression and Replication. Journal of Virology, Jan. 2002, vol. 76, No. 1, pp. 313-326.
Lundquist et al. A Strong Negative Transcriptional Regulatory Region between the Human Cytomegalovirus UL127 Gene and the Major Immediate-Early Enhancer. Journal of Virology, Nov. 1999, vol. 73, No. 11, pp. 9039-9053.
Isomura et al. The Human Cytomegalovirus Major Immediate-Early Enhancer Determines the Efficiency of Immediate-Early Gene Transcription and Viral Replication In Permissive Cells at Low Multiplicity of Infection. Journal of Virology, Mar. 2003, vol. 77, No. 6, pp. 3602-3614.
Macias et al. Cellular or Viral Protein Binding to a Cytomegalovirus Promoter Transcription Initiation Site: Effects on Transcription. Journal of Virology, Jun. 1996, vol. 70, No. 6, pp. 3628-3635.
Lashmit et al. Cellular Repressor Inhibits Human Cytomegalovirus Transcription from the UL127 Promoter. Journal of Virology, May 2004, pp. 5113-5123.
Lu et al., Endocrinology 137: 2959-2967, 1996.
Caldwell Jeremy S.
Chao Sheng-Hao
Genomics Institute of the Novartis Research Foundation
IRM LLC
Salimi Ali R.
Smith Timothy L.
LandOfFree
Methods and compositions for inhibiting herpesviral replication does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for inhibiting herpesviral replication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for inhibiting herpesviral replication will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3856253